ENVUE MEDICAL, INC.
Last · OTC Markets OTCPK$0.3512-0.0091 (-2.53%)stale · yahoo · 53h ago
Market cap$324409.00923.7K sh
P/E · TTM-0.0fwd — · eps -339.36 · loss
Beta1.45vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.20$79.43
Volume31.5Ksession
| Revenue | $2.6M |
|---|---|
| Operating income | $-22.9M |
| Net income | $-16.8M |
| Free cash flow | $-9.4M |
| Operating margin | -896.6% |
| Net margin | -657.1% |
| Return on equity | -50.1% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-04-15
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -657.1%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -367.1%
- Cash Runway Low — Cash runway ~0.5 years
- Accumulated Deficit High — Accumulated deficit / equity 270%
- Rd Intensity High — R&D/Revenue 69.0%
Press & signals
- GlobeNewswire
ENvue Medical Provides Nasdaq Listing Update
- GlobeNewswire
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
- GlobeNewswire
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags